Cardiovascular-Kidney-Metabolic Overlap in Heart Failure with Preserved Ejection Fraction: Cardiac Structure and Function, Clinical Outcomes, and Response to Sacubitril/Valsartan in PARAGON-HF
Mats Christian Højbjerg Lassen(University of Copenhagen), Muthiah Vaduganathan(Brigham and Women's Hospital), John W. Ostrominski(Brigham and Women's Hospital), John J.V. McMurray(University of Glasgow), Marc A. Pfeffer(Brigham and Women's Hospital), Amil M. Shah(Brigham and Women's Hospital), Milton Packer(Baylor University Medical Center), Michael R. Zile(Medical University of South Carolina), Scott D. Solomon(Brigham and Women's Hospital), Maja Čikeš, Mauro Gori(Ospedale Papa Giovanni XXIII), Martin Lefkowitz(Novartis (United States)), Sheila M. Hegde(Brigham and Women's Hospital), Béla Merkely(Semmelweis University), Brian Claggett(National Heart Lung and Blood Institute), Akshay S. Desai(Brigham and Women's Hospital), Xiaowen Wang(Brigham and Women's Hospital)
Cited by 22
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology
|Journal of the American Society of Echocardiography|2005|11.3k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Dapagliflozin in Patients with Chronic Kidney Disease
|New England Journal of Medicine|2020|5.2k